CB3717 is a potent inhibitor of human thymidylate synthase, used to disrupt nucleotide metabolism by competitively binding to 5,10-methylenetetrahydrofolate (Ki = 4.9 nM); it also competitively inhibits human dihydrofolate reductase by binding to dihydrofolate (Ki = 23 nM); its growth-inhibitory effects can be reversed by thymidine supplementation, indicating its application in studying thymidylate synthase-dependent cellular processes and as a potential antifolate chemotherapeutic agent.